Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3488382012 | Product containing ponatinib (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3716292011 | Ponatinib-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 852481000172117 | produit contenant du ponatinib | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 763711000172117 | product dat ponatinib bevat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing ponatinib (medicinal product) | Is a | Product containing protein-tyrosine kinase inhibitor (product) | true | Inferred relationship | Some | ||
| Product containing ponatinib (medicinal product) | Has active ingredient | Ponatinib | true | Inferred relationship | Some | 1 | |
| Product containing ponatinib (medicinal product) | Is a | Product containing enzyme inhibitor (product) | false | Inferred relationship | Some | ||
| Product containing ponatinib (medicinal product) | Is a | Product containing benzamide | false | Inferred relationship | Some | ||
| Product containing ponatinib (medicinal product) | Is a | Benzamide structure-containing product | true | Inferred relationship | Some | ||
| Product containing ponatinib (medicinal product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing ponatinib (medicinal product) | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Product containing ponatinib (medicinal product) | Inferred relationship | Some | |
| Ponatinib (as ponatinib hydrochloride) 45 mg oral tablet | Is a | False | Product containing ponatinib (medicinal product) | Inferred relationship | Some | |
| Ponatinib-containing product in oral dose form | Is a | True | Product containing ponatinib (medicinal product) | Inferred relationship | Some | |
| Product containing only ponatinib (medicinal product) | Is a | True | Product containing ponatinib (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR